Overcoming drug resistance in multiple myeloma: a study of intrinsic and extrinsic mechanisms. Vrije Universiteit Brussel
Multiple myeloma (MM) is a hematological cancer affecting around 25000 new patients in the EU. The introduction of new therapies including novel agents such as proteasome inhibitors and immunomodulatory drugs has led to a significantly improved survival rate.
However, relapse of the disease, as the result of the emergence of drug-resistant myeloma subclones remains the main obstacle on the road to cure. Bortezomib is part of the standard ...
However, relapse of the disease, as the result of the emergence of drug-resistant myeloma subclones remains the main obstacle on the road to cure. Bortezomib is part of the standard ...